Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Algavi is a French biotechnology company specializing in the development of high-value bioactive ingredients derived from microalgae. The company utilizes a proprietary biorefinery platform to cultivate specific microalgae strains and extract high-purity compounds for the nutraceutical, cosmetic, and pharmaceutical industries. Their flagship product is a highly concentrated phycocyanin extract, known for its potent antioxidant and anti-inflammatory properties. Algavi focuses on sustainable production methods, employing controlled photobioreactors and innovative cold extraction techniques to maintain the integrity of the molecules. The company aims to provide natural, science-backed solutions for immune support, recovery, and skin health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Algavi.